Recent AGE News
- AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results • GlobeNewswire Inc. • 03/22/2024 09:27:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/07/2024 09:49:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:47:08 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/07/2024 12:47:43 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:01:43 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/14/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:05:20 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/05/2024 12:19:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:05:39 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/17/2024 09:19:13 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 02:11:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:05:36 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/09/2024 09:16:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:02:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:25:54 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/13/2023 10:11:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:05:38 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/16/2023 09:01:20 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/15/2023 02:38:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:25:21 PM
- AgeX Therapeutics Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:05:00 PM
UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM
Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM
VAYK Confirmed Its Eligibility for $1.8 Million Investment through Federal EB5 Program • VAYK • Apr 11, 2024 9:00 AM
ILUS Moves Forward With Its Two Subsidiary Uplists and Equity Dividend • ILUS • Apr 10, 2024 9:36 AM
Quartz Intersects 102m of 2.22 g/t Au and 104 g/t Ag Announces New Discovery at Prodigy on its Maestro Project, British Columbia • QZM • Apr 10, 2024 8:00 AM
Swifty Global Announces Record Annual Results Ahead of National Exchange Reverse Merger • DRCR • Apr 9, 2024 1:55 PM